These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8816592)

  • 1. Multiparameter flow-cytometric analysis of bcl-2 and Fas expression in normal and neoplastic hematopoiesis.
    DiGiuseppe JA; LeBeau P; Augenbraun J; Borowitz MJ
    Am J Clin Pathol; 1996 Sep; 106(3):345-51. PubMed ID: 8816592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells.
    Lanza F; Castagnari B; Rigolin G; Moretti S; Latorraca A; Ferrari L; Bardi A; Castoldi G
    Leukemia; 1997 Oct; 11(10):1700-10. PubMed ID: 9324292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
    Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
    Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression.
    Zhou M; Gu L; Yeager AM; Findley HW
    Leukemia; 1998 Nov; 12(11):1756-63. PubMed ID: 9823951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative quantitative expression of bcl-2 by normal and leukaemic myeloid cells.
    Bradbury DA; Russell NH
    Br J Haematol; 1995 Oct; 91(2):374-9. PubMed ID: 8547078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
    Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
    Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status.
    Egle A; Villunger A; Marschitz I; Kos M; Hittmair A; Lukas P; Grünewald K; Greil R
    Br J Haematol; 1997 May; 97(2):418-28. PubMed ID: 9163609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.
    Porwit-MacDonald A; Ivory K; Wilkinson S; Wheatley K; Wong L; Janossy G
    Leukemia; 1995 Jul; 9(7):1191-8. PubMed ID: 7543174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome].
    Zhang Z; Xie J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 expression in acute myeloblastic leukaemia: relationship with autonomous growth and CD34 antigen expression.
    Bradbury DA; Zhu YM; Russell NH
    Leuk Lymphoma; 1997 Jan; 24(3-4):221-8. PubMed ID: 9156652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis.
    Lickliter JD; Kratzke RA; Nguyen PL; Niehans GA; Miller JS
    Exp Hematol; 1999 Oct; 27(10):1519-27. PubMed ID: 10517493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
    Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells.
    Delia D; Aiello A; Soligo D; Fontanella E; Melani C; Pezzella F; Pierotti MA; Della Porta G
    Blood; 1992 Mar; 79(5):1291-8. PubMed ID: 1536952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.
    Coustan-Smith E; Kitanaka A; Pui CH; McNinch L; Evans WE; Raimondi SC; Behm FG; Aricò M; Campana D
    Blood; 1996 Feb; 87(3):1140-6. PubMed ID: 8562940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moloney murine leukemia virus-induced tumors show altered levels of proapoptotic and antiapoptotic proteins.
    Bonzon C; Fan H
    J Virol; 2000 Sep; 74(17):8151-8. PubMed ID: 10933726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia.
    Aref S; Salama O; Al-Tonbary Y; Mansour A
    Hematology; 2004 Apr; 9(2):113-21. PubMed ID: 15203866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells.
    Rajapaksa R; Ginzton N; Rott LS; Greenberg PL
    Blood; 1996 Dec; 88(11):4275-87. PubMed ID: 8943864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Icariin on apoptosis and expression of Fas, Fas ligand, B cell lymphoma, and Bcl-2-associated X protein in CD4+ T lymphocytes from patients with ankylosing spondylitis.
    Wang H; Jiang Q; Feng X
    J Tradit Chin Med; 2017 Apr; 37(2):207-13. PubMed ID: 29960293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
    Wuchter C; Karawajew L; Ruppert V; Büchner T; Schoch C; Haferlach T; Ratei R; Dörken B; Ludwig WD
    Leukemia; 1999 Dec; 13(12):1943-53. PubMed ID: 10602414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
    Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
    Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.